Wealthcare Advisory Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-4,410
Closed -$318K – 614
2022
Q1
$318K Sell
4,410
-2
-0% -$144 0.02% 400
2021
Q4
$405K Sell
4,412
-627
-12% -$74.9K 0.02% 366
2021
Q3
$639K Sell
5,039
-28
-0.6% -$4.08K 0.04% 273
2021
Q2
$843K Buy
5,067
+503
+11% +$81.5K 0.06% 221
2021
Q1
$830K Buy
4,564
+3,317
+266% +$769K 0.06% 212
2020
Q4
$249K Buy
1,247
+309
+33% +$62.8K 0.02% 358
2020
Q3
$206K Buy
+938
New +$199K 0.02% 331
2020
Q2
– Sell
-767
Closed -$119K – 1236
2020
Q1
$119K Buy
767
+37
+5% +$4.3K 0.02% 346
2019
Q4
$61K Sell
730
-75
-9% -$5.71K 0.01% 505
2019
Q3
$55K Buy
805
+605
+303% +$39.8K 0.01% 509
2019
Q2
$13K Hold
200
– – ﹤0.01% 850
2019
Q1
$11K Hold
200
– – ﹤0.01% 799
2018
Q4
$10K Hold
200
– – ﹤0.01% 795
2018
Q3
$17K Buy
+200
New +$14.3K ﹤0.01% 723

Other funds holding TDOC

Wealthcare Advisory Partners's TDOC Position: Q2 2022 in Review

Wealthcare Advisory Partners sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 4,410 shares — an estimated $318K sold.

Wealthcare Advisory Partners first reported a position in TDOC in Q3 2018 and held it in 14 quarters. The position peaked at $843K in Q2 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Wealthcare Advisory Partners reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 4,410 Teladoc Health shares in Q2 2022, an estimated $318K.
  • Wealthcare Advisory Partners first reported a position in Teladoc Health in Q3 2018 and held it in 14 quarters.
  • Wealthcare Advisory Partners's Teladoc Health position peaked at $843K in Q2 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2022, filed 15 Aug 2022.